Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19

Approximately 5% of people with Covid-19 progress to a severe or critical form, including the development of severe pneumonia that progresses to acute respiratory distress syndrome.
Read More


>>Hollywood's Exotic Secret For Healthy Weight Loss

0 Response to "Type 1 interferon deficiency as a biomarker for detecting patients at risk of severe COVID-19"

Post a Comment